| Lantern Pharma Inc. |
| 1920 McKinney Avenue, 7th Floor |
| Dallas, Texas 75201 |
December 16, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Lantern Pharma Inc. | |
| Draft Registration Statement on Form S-1 | ||
| Confidentially Submitted: December 16, 2020 | ||
Ladies and Gentlemen:
In connection with confidential submission of a Draft Registration Statement on Form S-1 by the undersigned, Lantern Pharma Inc. (the “Company”), the Company hereby undertakes to publicly file its Registration Statement on Form S-1 and the nonpublic Draft Registration Statement such that both are publicly available on the EDGAR system at least 48 hours prior to any requested effective time and date.
Please do not hesitate to contact me, at (628) 777-3339 or panna@lanternpharma.com, or the Company’s counsel, Daniel Donahue of Greenberg Traurig, LLP, at (949) 732-6557 or donahued@gtlaw.com, with any questions or comments.
| Very truly yours, | ||
| Lantern Pharma Inc. | ||
| By: |
/s/ Panna Sharma |
|
| Panna Sharma, | ||
| President and Chief Executive Officer | ||
| cc: | Daniel Donahue, Greenberg Traurig, LLP |